Literature DB >> 15519429

Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome.

John R Barton1, Baha M Sibai.   

Abstract

Pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome require a well-formulated management plan. The development of this syndrome after 34 weeks' gestation or with documentation of maternal or fetal compromise is an indication for delivery. Acute fatty liver of pregnancy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura may present with signs, symptoms, and laboratory abnormalities that may be confused with HELLP syndrome. Thorough investigation is warranted because of the differences in proper management among these various complications of pregnancy. Expectant management in patients with HELLP syndrome remote from term and the use of corticosteroids to improve postpartum maternal outcome remain experimental.

Entities:  

Mesh:

Year:  2004        PMID: 15519429     DOI: 10.1016/j.clp.2004.06.008

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  32 in total

1.  Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic, and HELLP pregnancies.

Authors:  I Mylonas; B Schiessl; U Jeschke; J Vogl; A Makrigiannakis; C Kuhn; S Schulze; F Kainer; K Friese
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

2.  Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.

Authors:  Szilvia Szabo; Yi Xu; Roberto Romero; Tibor Fule; Katalin Karaszi; Gaurav Bhatti; Tibor Varkonyi; Ildiko Varkonyi; Tibor Krenacs; Zhong Dong; Adi L Tarca; Tinnakorn Chaiworapongsa; Sonia S Hassan; Zoltan Papp; Ilona Kovalszky; Nandor Gabor Than
Journal:  Virchows Arch       Date:  2013-06-27       Impact factor: 4.064

Review 3.  Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management.

Authors:  Prem S Shekhawat; Dietrich Matern; Arnold W Strauss
Journal:  Pediatr Res       Date:  2005-04-06       Impact factor: 3.756

4.  Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods.

Authors:  Daniel B DiGiulio; Mariateresa Gervasi; Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Kimberley S Seok; Ricardo Gómez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Enrique Oyarzún; Chong Jai Kim; David A Relman
Journal:  J Perinat Med       Date:  2010-09       Impact factor: 1.901

5.  An intensive care approach to posterior reversible encephalopathy syndrome (PRES): An analysis of 7 cases.

Authors:  İsmail Demirel; Burçin Salih Kavak; Ayşe B Özer; Mustafa K Bayar; Ömer L Erhan
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-12-01

6.  Hypertensive disorders of pregnancy.

Authors:  Alessia Mammaro; Sabina Carrara; Alessandro Cavaliere; Santina Ermito; Angela Dinatale; Elisa Maria Pappalardo; Mariapia Militello; Rosa Pedata
Journal:  J Prenat Med       Date:  2009-01

7.  Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar.

Authors:  T Várkonyi; B Nagy; T Füle; A L Tarca; K Karászi; J Schönléber; P Hupuczi; N Mihalik; I Kovalszky; J Rigó; H Meiri; Z Papp; R Romero; N G Than
Journal:  Placenta       Date:  2010-06-11       Impact factor: 3.481

Review 8.  Immune thrombocytopenia in pregnancy.

Authors:  Evi Stavrou; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2009-12       Impact factor: 3.722

9.  Proteomic identification of Placental Protein 1 (PP1), PP8, and PP22 and characterization of their placental expression in healthy pregnancies and in preeclampsia.

Authors:  Szilvia Szabo; Katalin Karaszi; Roberto Romero; Eszter Toth; Andras Szilagyi; Zsolt Gelencser; Yi Xu; Andrea Balogh; Gabor Szalai; Petronella Hupuczi; Beata Hargitai; Tibor Krenacs; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Katalin A Kekesi; Adi L Tarca; Offer Erez; Gabor Juhasz; Ilona Kovalszky; Zoltan Papp; Nandor Gabor Than
Journal:  Placenta       Date:  2020-06-22       Impact factor: 3.481

10.  First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Authors:  Roberto Romero; Juan Pedro Kusanovic; Nandor Gabor Than; Offer Erez; Francesca Gotsch; Jimmy Espinoza; Samuel Edwin; Ilana Chefetz; Ricardo Gomez; Jyh Kae Nien; Marei Sammar; Beth Pineles; Sonia S Hassan; Hamutal Meiri; Yossi Tal; Ido Kuhnreich; Zoltan Papp; Howard S Cuckle
Journal:  Am J Obstet Gynecol       Date:  2008-06-09       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.